Despite repeated warnings that critical drugs have been and will remain in short supply, corrective action has been painfully elusive.
A confluence of factors contribute to the persistence of the problem. These factors have been identified multiple times over the years, but addressing them and their effects on patients’ health requires overall system changes that call for full congressional and business cooperation. The current blog does not cover the policy changes needed for improvement; they are beyond its scope. However, it […]